QuidelOrtho CEO Named Chair of AdvaMedDx Board
QuidelOrtho CEO Brian J. Blaser has been appointed chair of the AdvaMedDx board, leading the diagnostics division representing 70-plus IVD manufacturers.
Read MorePosted by CLP Edit Staff | Jan 21, 2026 | Diagnostic Technologies |
QuidelOrtho CEO Brian J. Blaser has been appointed chair of the AdvaMedDx board, leading the diagnostics division representing 70-plus IVD manufacturers.
Read MorePosted by CLP Edit Staff | Jan 20, 2026 | Dementias & Alzheimer’s |
A large-scale international trial is evaluating a finger prick blood test for Alzheimer’s, analyzing three protein biomarkers as a potential alternative to PET scans and lumbar punctures.
Read MorePosted by CLP Edit Staff | Jan 14, 2026 | Sexually Transmitted Diseases |
Nexus Medical Labs will implement Lybe Scientific’s NAxtra nucleic acid extraction kit in a 60,000-plus test unit deal to enhance high-throughput STI testing, citing improved detection limits and workflow efficiency.
Read MorePosted by CLP Edit Staff | Jan 5, 2026 | Molecular Diagnostics |
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
Read MorePosted by CLP Edit Staff | Jan 2, 2026 | Allergy & Autoimmune |
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.
Read More